Max-Planck-Gesel. Zur Foerderung Der Wissen. E.V.
|Max-Planck-Gesel. Zur Foerderung Der Wissen. E.V. Patent applications|
|Patent application number||Title||Published|
|20130017597||USE OF BIOLOGICAL PHOTORECEPTORS AS DIRECTLY LIGHT-ACTIVATED ION CHANNELS - Use of a biological photoreceptor as light-controlled ion channel for the alteration of the ion conductivity of a membrane by means of light. The photoreceptor used comprises an apoprotein and a light-sensitive polyene covalently bound to the apoprotein, said polyene interacting with the apoprotein and functioning as a light-sensitive gate.||01-17-2013|
|20120283432||USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS - Use of rylene derivatives I||11-08-2012|
|20110101329||HIGH PERFORMANCE SOLUTION PROCESSABLE SEMICONDUCTING POLYMERS BASED ON AL-TERNATING DONOR ACCEPTOR COPOLYMERS - A benzothiadiazol-cyclopentadithiophene copolymer comprising as repeating unit the group of the formula (I) wherein R is n-hexadecyl or 3,7-dimethyloctyl, and having a number average molecular weight Mn in the range of from 30 to 70 kg/mol is disclosed. The invention also relates to the use of the copolymers as semiconductors or charge transport materials, as thin-film transistors (TFTs), or in semiconductor components for organic light-emitting diodes (OLEDs), for photovoltaic components or in sensors, as an electrode material in batteries, as optical waveguides or for electrophotography applications.||05-05-2011|
|20080206881||DIAGNOSTIC MARKER FOR NEURODEGENERATIVE DISEASES - For neurodegenerative diseases such as amyotrophic lateral sclerosis the prediction of disease progression or response to therapy based on phenotypic parameters is very difficult and inaccurate. The measurement of the serum protein carbonyl content allows a quantitative and early diagnosis of these diseases. It enables the monitoring of the disease progression as well as the individual adjustment of the therapy. Furthermore, this diagnostic marker can be used as a readout in animal model based screening methods for new therapeutic approaches and compounds.||08-28-2008|
Patent applications by Max-Planck-Gesel. Zur Foerderung Der Wissen. E.V.